REPORT ID 5189

EMEA (Europe, Middle East and Africa) Behcet Disease Drug Market Report 2017

Publish Date
20-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the EMEA Behcet Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Behcet Disease Drug for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Behcet Disease Drug market competition by top manufacturers/players, with Behcet Disease Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AbbVie Inc
    Celgene Corp
    Cell Medica Ltd
    Coherus BioSciences Inc
    Genor BioPharma Co Ltd
    Novartis AG
    Panacea Biotec Ltd
    R Pharm

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Adalimumab Biosimilar
    Apremilast
    Canakinumab
    Infliximab Biosimilar
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Home Care
    Hospital
    Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Behcet Disease Drug Market Report 2017
1 Behcet Disease Drug Overview
    1.1 Product Overview and Scope of Behcet Disease Drug
    1.2 Classification of Behcet Disease Drug
        1.2.1 EMEA Behcet Disease Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Behcet Disease Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Adalimumab Biosimilar
        1.2.4 Apremilast
        1.2.5 Canakinumab
        1.2.6 Infliximab Biosimilar
        1.2.7 Others
    1.3 EMEA Behcet Disease Drug Market by Application/End Users
        1.3.1 EMEA Behcet Disease Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Home Care
        1.3.3 Hospital
        1.3.4 Clinic
    1.4 EMEA Behcet Disease Drug Market by Region
        1.4.1 EMEA Behcet Disease Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Behcet Disease Drug (2012-2022)
        1.5.1 EMEA Behcet Disease Drug Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Behcet Disease Drug Revenue and Growth Rate (2012-2022)

2 EMEA Behcet Disease Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Behcet Disease Drug Market Competition by Players/Manufacturers
        2.1.1 EMEA Behcet Disease Drug Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Behcet Disease Drug Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Behcet Disease Drug Sale Price by Players (2012-2017)
    2.2 EMEA Behcet Disease Drug (Volume and Value) by Type/Product Category
        2.2.1 EMEA Behcet Disease Drug Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Behcet Disease Drug Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Behcet Disease Drug Sale Price by Type (2012-2017)
    2.3 EMEA Behcet Disease Drug (Volume) by Application
    2.4 EMEA Behcet Disease Drug (Volume and Value) by Region
        2.4.1 EMEA Behcet Disease Drug Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Behcet Disease Drug Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Behcet Disease Drug Sales Price by Region (2012-2017)

3 Europe Behcet Disease Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Behcet Disease Drug Sales and Value (2012-2017)
        3.1.1 Europe Behcet Disease Drug Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Behcet Disease Drug Revenue and Growth Rate (2012-2017)
    3.2 Europe Behcet Disease Drug Sales and Market Share by Type
    3.3 Europe Behcet Disease Drug Sales and Market Share by Application
    3.4 Europe Behcet Disease Drug Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Behcet Disease Drug Sales Volume by Countries (2012-2017)
        3.4.2 Europe Behcet Disease Drug Revenue by Countries (2012-2017)
        3.4.3 Germany Behcet Disease Drug Sales and Growth Rate (2012-2017)
        3.4.4 France Behcet Disease Drug Sales and Growth Rate (2012-2017)
        3.4.5 UK Behcet Disease Drug Sales and Growth Rate (2012-2017)
        3.4.6 Russia Behcet Disease Drug Sales and Growth Rate (2012-2017)
        3.4.7 Italy Behcet Disease Drug Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Behcet Disease Drug Sales and Growth Rate (2012-2017)

4 Middle East Behcet Disease Drug (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Behcet Disease Drug Sales and Value (2012-2017)
        4.1.1 Middle East Behcet Disease Drug Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Behcet Disease Drug Revenue and Growth Rate (2012-2017)
    4.2 Middle East Behcet Disease Drug Sales and Market Share by Type
    4.3 Middle East Behcet Disease Drug Sales and Market Share by Application
    4.4 Middle East Behcet Disease Drug Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Behcet Disease Drug Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Behcet Disease Drug Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Behcet Disease Drug Sales and Growth Rate (2012-2017)
        4.4.4 Israel Behcet Disease Drug Sales and Growth Rate (2012-2017)
        4.4.5 UAE Behcet Disease Drug Sales and Growth Rate (2012-2017)
        4.4.6 Iran Behcet Disease Drug Sales and Growth Rate (2012-2017)

5 Africa Behcet Disease Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Behcet Disease Drug Sales and Value (2012-2017)
        5.1.1 Africa Behcet Disease Drug Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Behcet Disease Drug Revenue and Growth Rate (2012-2017)
    5.2 Africa Behcet Disease Drug Sales and Market Share by Type
    5.3 Africa Behcet Disease Drug Sales and Market Share by Application
    5.4 Africa Behcet Disease Drug Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Behcet Disease Drug Sales Volume by Countries (2012-2017)
        5.4.2 Africa Behcet Disease Drug Revenue by Countries (2012-2017)
        5.4.3 South Africa Behcet Disease Drug Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Behcet Disease Drug Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Behcet Disease Drug Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Behcet Disease Drug Sales and Growth Rate (2012-2017)

6 EMEA Behcet Disease Drug Manufacturers/Players Profiles and Sales Data
    6.1 AbbVie Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Behcet Disease Drug Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AbbVie Inc Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Celgene Corp
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Behcet Disease Drug Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Celgene Corp Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Cell Medica Ltd
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Behcet Disease Drug Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Cell Medica Ltd Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Coherus BioSciences Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Behcet Disease Drug Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Coherus BioSciences Inc Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Genor BioPharma Co Ltd
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Behcet Disease Drug Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Genor BioPharma Co Ltd Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Novartis AG
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Behcet Disease Drug Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis AG Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Panacea Biotec Ltd
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Behcet Disease Drug Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Panacea Biotec Ltd Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 R Pharm
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Behcet Disease Drug Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 R Pharm Behcet Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Behcet Disease Drug Manufacturing Cost Analysis
    7.1 Behcet Disease Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Behcet Disease Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Behcet Disease Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Behcet Disease Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Behcet Disease Drug Market Forecast (2017-2022)
    11.1 EMEA Behcet Disease Drug Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Behcet Disease Drug Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Behcet Disease Drug Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Behcet Disease Drug Price and Trend Forecast (2017-2022)
    11.2 EMEA Behcet Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Behcet Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Behcet Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Behcet Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Behcet Disease Drug Sales Forecast by Type (2017-2022)
    11.7 EMEA Behcet Disease Drug Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer